The ACC's Heart Failure and Transplant Member Section and Leadership Council is the home for heart failure and transplant specialists within the ACC, advocating for and advancing priorities of interest to the community.
Maya Guglin, MD Ph.D., FACC
Director of Heart Failure/Heart Transplantation/MCS Services
Professor, Indiana University School of Medicine
Krannert Institute of Cardiology
Combining a unique blend of forum and network, the Heart Failure and Transplant Member Section and Leadership Council represents the heart failure community by identifying, developing and implementing initiatives related to heart failure and acts as a liaison between heart failure specialists and ACC leadership.
Become a Member — Join Now.
Serve as a voice for the heart failure and transplant specialists and become a part of the Heart Failure and Transplant Member Section today. To join, call ACC Member Care at (800) 253-4636, ext. 5603 or check the box on your dues statement each Fall.
The Heart Failure Section membership provides participants with opportunities to make a difference in heart failure and:
Network with colleagues
Develop leadership skills
Advance your career
Strengthen your skills
Expand upon your interests within the specialty
Message From the Chair
The Heart Failure Member Section is the home for health care professionals involved in all aspects of care for patients with heart failure. This includes all spectrums of heart failure including acute and chronic heart failure, critical care and shock, mechanical circulatory support devices, heart transplantation and pulmonary hypertension. Read more >>>
Heart failure is a significant global epidemic; however, there may be sex-related differences in the epidemiology, pathophysiology, risk factors, and outcomes. To highlight the latest and most impactful science from the growing body of literature on this topic, JACC: Heart Failure will publish a new special issue in September of this year.
Improve heart health for all with ACC's latest HeartFailure tools & resources available to clinicians, patients & facilities. Check out the resources here.
What You Need to Know: Guidance For Clinicians on Dobutamine Shortage
The current dobutamine shortage affects multiple areas in cardiovascular medicine, including diagnostics and therapies. According to manufacturers, the crisis will be relieved in the fall of 2022 and resolved by the end of this year.
This document was developed by the ACC Heart Failure and Transplant Member Section, ACC Cardiovascular Team Section, and the University of Utah Health.
Clinical Topic Collections gather ACC's most recent content on the subjects most important to you. Click the links below to view ACC.org's latest content from the Heart Failure and Cardiomyopathies collection.